tiprankstipranks
Trending News
More News >
Clinigence Holdings (NUTX)
NASDAQ:NUTX
US Market

Clinigence Holdings (NUTX) Ratios

Compare
221 Followers

Clinigence Holdings Ratios

NUTX's free cash flow for Q4 2024 was $0.55. For the 2024 fiscal year, NUTX's free cash flow was decreased by $ and operating cash flow was $0.44. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.08 1.56 1.79 4.09 4.31
Quick Ratio
2.06 1.50 1.72 4.01 4.25
Cash Ratio
0.31 0.38 0.62 0.96 0.81
Solvency Ratio
<0.01 -0.09 -1.35 0.69 0.66
Operating Cash Flow Ratio
0.16 0.02 0.92 4.60 2.58
Short-Term Operating Cash Flow Coverage
0.96 0.09 3.34 16.95 4.36
Net Current Asset Value
$ -160.95B$ -228.29M$ -213.45M$ -49.05M$ -25.68M
Leverage Ratios
Debt-to-Assets Ratio
0.48 0.69 0.62 0.45 0.49
Debt-to-Equity Ratio
1.56 4.49 2.79 1.56 1.75
Debt-to-Capital Ratio
0.61 0.82 0.74 0.61 0.64
Long-Term Debt-to-Capital Ratio
0.59 0.30 0.19 0.41 0.49
Financial Leverage Ratio
3.25 6.48 4.50 3.44 3.60
Debt Service Coverage Ratio
<0.01 -0.31 -14.72 11.11 -2.23
Interest Coverage Ratio
6.55 -1.95 -0.41 27.48 23.68
Debt to Market Cap
1.94K 0.34 <0.01 <0.01 <0.01
Interest Debt Per Share
61.63K 66.26 6.62 4.60 3.65
Net Debt to EBITDA
1.82K -17.40 -0.59 0.78 -24.35
Profitability Margins
Gross Profit Margin
40.89%14.04%6.13%54.08%99.33%
EBIT Margin
27.02%-12.99%-185.67%52.99%56.02%
EBITDA Margin
30.97%-5.89%-179.65%55.33%-1.87%
Operating Profit Margin
27.22%-12.83%-2.34%51.36%55.71%
Pretax Profit Margin
22.87%-19.58%-191.36%51.12%53.24%
Net Profit Margin
10.87%-18.49%-197.33%39.99%38.76%
Continuous Operations Profit Margin
19.85%-17.53%-197.33%50.83%53.24%
Net Income Per EBT
47.54%94.42%103.12%78.23%72.80%
EBT Per EBIT
84.02%152.61%8167.95%99.55%95.55%
Return on Assets (ROA)
<0.01%-11.50%-100.23%33.60%34.34%
Return on Equity (ROE)
0.03%-74.51%-451.42%115.65%123.50%
Return on Capital Employed (ROCE)
0.03%-9.35%-1.36%47.70%54.97%
Return on Invested Capital (ROIC)
0.02%-7.90%-1.33%45.74%33.32%
Return on Tangible Assets
<0.01%-12.69%-109.96%33.75%34.47%
Earnings Yield
32.29%-38.47%-3.59%0.05%0.04%
Efficiency Ratios
Receivables Turnover
<0.01 3.94 3.76 2.89 2.53
Payables Turnover
20.32 8.42 8.60 8.62 0.21
Inventory Turnover
0.10 62.78 58.26 54.10 1.05
Fixed Asset Turnover
<0.01 0.92 0.74 1.39 1.60
Asset Turnover
<0.01 0.62 0.51 0.84 0.89
Working Capital Turnover Ratio
<0.01 6.55 2.75 3.01 7.04
Cash Conversion Cycle
180.43K 54.99 60.89 90.77 -1.24K
Days of Sales Outstanding
176.78K 92.52 97.06 126.34 144.36
Days of Inventory Outstanding
3.67K 5.81 6.27 6.75 346.17
Days of Payables Outstanding
17.96 43.35 42.43 42.32 1.73K
Operating Cycle
180.44K 98.34 103.33 133.09 490.53
Cash Flow Ratios
Operating Cash Flow Per Share
4.54K 0.29 1.20 4.32 1.89
Free Cash Flow Per Share
4.54K -1.87 0.85 3.40 0.47
CapEx Per Share
0.45 2.15 0.35 0.92 1.43
Free Cash Flow to Operating Cash Flow
1.00 -6.56 0.71 0.79 0.25
Dividend Paid and CapEx Coverage Ratio
2.65K 0.13 0.77 0.96 0.68
Capital Expenditure Coverage Ratio
10.05K 0.13 3.46 4.70 1.33
Operating Cash Flow Coverage Ratio
0.07 <0.01 0.19 0.97 0.54
Operating Cash Flow to Sales Ratio
48.24 <0.01 0.23 0.52 0.30
Free Cash Flow Yield
14326.08%-6.92%0.30%0.06%<0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
3.10 -2.60 -27.84 1.82K 2.43K
Price-to-Sales (P/S) Ratio
0.34 0.48 54.93 727.17 941.75
Price-to-Book (P/B) Ratio
<0.01 1.94 125.66 2.10K 3.00K
Price-to-Free Cash Flow (P/FCF) Ratio
<0.01 -14.44 334.85 1.77K 12.83K
Price-to-Operating Cash Flow Ratio
<0.01 94.73 238.03 1.39K 3.17K
Price-to-Earnings Growth (PEG) Ratio
-0.02 -1.77 0.07 71.66 4.26
Price-to-Fair Value
<0.01 1.94 125.66 2.10K 3.00K
Enterprise Value Multiple
1.82K -25.57 -31.17 1.31K -50.34K
EV to EBITDA
1.82K -25.57 -31.17 1.31K -50.34K
EV to Sales
564.35 1.51 55.99 727.60 942.20
EV to Free Cash Flow
11.70 -45.24 341.32 1.77K 12.83K
EV to Operating Cash Flow
11.70 296.69 242.63 1.39K 3.17K
Tangible Book Value Per Share
33.81K 9.42 1.94 4.72 3.41
Shareholders’ Equity Per Share
39.59K 13.94 2.27 2.85 2.00
Tax and Other Ratios
Effective Tax Rate
0.13 0.10 -0.03 <0.01 0.35
Revenue Per Share
94.11 56.18 5.19 8.25 6.37
Net Income Per Share
10.23 -10.39 -10.24 3.30 2.47
Tax Burden
0.48 0.94 1.03 0.78 0.73
Interest Burden
0.85 1.51 1.03 0.96 0.95
Research & Development to Revenue
0.00 0.00 0.00 <0.01 <0.01
SG&A to Revenue
87.35 0.13 0.08 0.02 0.42
Stock-Based Compensation to Revenue
34.65 0.01 <0.01 0.00 <0.01
Income Quality
243.03 -0.03 -0.12 1.03 0.56
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis